Series C Investors & VC Firms in Ireland

25 firms in this list, with a median first check of $1.1M. 4 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
AT Atomico NZBBCRCA49 people · Follows rounds	88🔒	London	GB	Seed–Late Stage	—	+ Add to CRM
ME Metaplanet JTRMSBUJ4 people · Follows rounds	88🔒	Tallinn	EE	Seed–Late Stage	$500K – $10M	+ Add to CRM
LI Lightstone Ventures HPJGMCCG30 people · Leads rounds	88🔒	Portola Valley	US	Pre-Seed–Late Stage	—	+ Add to CRM
EQ EQT Life Sciences PFAPBJBH39 people · Leads rounds	88🔒	Luxembourg	LU	Seed–Late Stage	$11M – $66M	+ Add to CRM
HE HealthCap MSTRVMAF30 people	88🔒	Stockholm	SE	Seed–Growth	—	+ Add to CRM
EU European Circular Bioeconomy Fund DSMBMNIL24 people	88🔒	Bonn	DE	Series A–Late Stage	$5.5M – $16.5M	+ Add to CRM
BU Business Venture Partners SBSTEGSM14 people	88🔒	Dublin	IE	Seed–Growth	—	+ Add to CRM
GI Gilde Healthcare AFEDGPHD24 people · Follows rounds	88🔒	Utrecht	NL	Seed–Late Stage	$1.1M – $55M	+ Add to CRM
50 500 Startups CTBYCPKN8 people · Leads rounds	88🔒	San Francisco	US	Pre-Seed–Late Stage	$10K – $250K	+ Add to CRM
EN Enterprise Ireland KSMCPMAO23 people	88🔒	Dublin	IE	Pre-Seed–Growth	—	+ Add to CRM
SE Seroba Life Sciences BMJMMLJB13 people	88🔒	Dublin	IE	Seed–Late Stage	$540K – $7.6M	+ Add to CRM
FO Foresight Group BFATACAB16 people	88🔒	London	GB	Seed–Late Stage	$1.3M – $6.3M	+ Add to CRM
KE Kernel Capital CODWDSDD9 people	88🔒	Cork	IE	Seed–Late Stage	$1.1M – $5.4M	+ Add to CRM
CL Clay Capital MDMVAMGC16 people	88🔒	—	SG	Seed–Late Stage	$3M – $8M	+ Add to CRM
EN Enterprise Equity COFWTSCO4 people	88🔒	Dundalk	IE	Pre-Seed–Late Stage	$81K – $1.6M	+ Add to CRM
AC ACT Venture Capital JFDRCMCM10 people	88🔒	Dublin	IE	Seed–Growth	$1.1M – $16.2M	+ Add to CRM
EU Eurazeo LGLMMTNW12 people	88🔒	Paris	FR	Series A–Late Stage	—	+ Add to CRM
PA Panakes Partners ABDSFLBC11 people · Follows rounds	88🔒	Milan	IT	Seed–Late Stage	—	+ Add to CRM
VE Verdane BKCJDAEJ11 people	88🔒	Stockholm	NO	Series B–Growth	$21.6M – $162M	+ Add to CRM
AL Alpina Partners FSPS2 people · Leads rounds	88🔒	Munich	DE	Series A–Late Stage	$635K – $2.5M	+ Add to CRM
LI Liberty Growth MBPM2 people	88🔒	London	GB	Series B–Late Stage	$5M – $10M	+ Add to CRM
WA Wayflyer Follows rounds	88🔒	Dublin	IE	Series A–Growth	$5K – $20M	+ Add to CRM
IA IAGi Ventures	88🔒	London	GB	Pre-Seed–Growth	—	+ Add to CRM
SW Swisscom Ventures	88🔒	Zürich	CH	Seed–Growth	$1M – $20M	+ Add to CRM

Atomico

LondonSeed–Late Stage

NZBBCRCA49 people

Metaplanet

TallinnSeed–Late Stage$500K – $10M

JTRMSBUJ4 people

Lightstone Ventures

Portola ValleyPre-Seed–Late Stage

HPJGMCCG30 people

EQT Life Sciences

LuxembourgSeed–Late Stage$11M – $66M

PFAPBJBH39 people

HealthCap

StockholmSeed–Growth

MSTRVMAF30 people

European Circular Bioeconomy Fund

BonnSeries A–Late Stage$5.5M – $16.5M

DSMBMNIL24 people

Business Venture Partners

DublinSeed–Growth

SBSTEGSM14 people

Gilde Healthcare

UtrechtSeed–Late Stage$1.1M – $55M

AFEDGPHD24 people

500 Startups

San FranciscoPre-Seed–Late Stage$10K – $250K

CTBYCPKN8 people

Enterprise Ireland

DublinPre-Seed–Growth

KSMCPMAO23 people

Seroba Life Sciences

DublinSeed–Late Stage$540K – $7.6M

BMJMMLJB13 people

Foresight Group

LondonSeed–Late Stage$1.3M – $6.3M

BFATACAB16 people

Kernel Capital

CorkSeed–Late Stage$1.1M – $5.4M

CODWDSDD9 people

Clay Capital

Seed–Late Stage$3M – $8M

MDMVAMGC16 people

Enterprise Equity

DundalkPre-Seed–Late Stage$81K – $1.6M

COFWTSCO4 people

ACT Venture Capital

DublinSeed–Growth$1.1M – $16.2M

JFDRCMCM10 people

Eurazeo

ParisSeries A–Late Stage

LGLMMTNW12 people

Panakes Partners

MilanSeed–Late Stage

ABDSFLBC11 people

Verdane

StockholmSeries B–Growth$21.6M – $162M

BKCJDAEJ11 people

Alpina Partners

MunichSeries A–Late Stage$635K – $2.5M

FSPS2 people

Liberty Growth

LondonSeries B–Late Stage$5M – $10M

MBPM2 people

Wayflyer

DublinSeries A–Growth$5K – $20M

IAGi Ventures

LondonPre-Seed–Growth

Swisscom Ventures

ZürichSeed–Growth$1M – $20M

Data sourced from public filings and firms' own websites — see our methodology.